Man Group
ALT icon

Man Group’s Altimmune ALT Stock Holding History

Man Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$400K Buy
129,846
+110,910
+586% +$471K ﹤0.01% 2138
2025
Q4 		$68.4K Buy
+18,936
New +$82.6K ﹤0.01% 2216
2023
Q3 		– Sell
-32,723
Closed -$93.9K – 1792
2023
Q2 		$116K Buy
+32,723
New +$147K ﹤0.01% 1871
2023
Q1 		– Sell
-12,226
Closed -$145K – 1856
2022
Q4 		$201K Buy
+12,226
New +$137K ﹤0.01% 1769
2020
Q4 		– Sell
-16,400
Closed -$216K – 1812
2020
Q3 		$216K Buy
+16,400
New +$328K ﹤0.01% 1692

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Man Group's ALT Position: Q1 2026 in Review

Man Group increased its Altimmune (ALT) stake by 586% in Q1 2026, buying an estimated $471K and bringing the position to 129,846 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #2138.

Man Group first reported a position in ALT in Q3 2020 and has held it in 5 quarters since. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Man Group held 129,846 shares of Altimmune worth $400K as of Q1 2026.
  • Man Group bought 110,910 Altimmune shares in Q1 2026, an estimated $471K.
  • Altimmune made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2138 holding.
  • Man Group first reported a position in Altimmune in Q3 2020 and has held it in 5 quarters since.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.